Magic mushroom compound tested for brain disorder
NCT ID NCT05723276
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 35 times
Summary
This study looks at how a single dose of psilocybin, the active ingredient in magic mushrooms, affects brain activity in people with functional neurological disorder (FND). Researchers will use brain scans to see if psilocybin can change a key brain network linked to FND. The study involves 24 adults aged 25-60 with moderate to severe FND that hasn't improved with standard treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNCTIONAL NEUROLOGICAL DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
South London and Maudsley NHS Foundation Trust
London, United Kingdom
Conditions
Explore the condition pages connected to this study.